Soft-tissue extramedullary multiple myeloma prognosis is significantly worse in comparison to bone-related extramedullary relapse. - Wikidata - wikimedia - TriplyDB

Soft-tissue extramedullary multiple myeloma prognosis is significantly worse in comparison to bone-related extramedullary relapse.

Soft-tissue extramedullary multiple myeloma prognosis is significantly worse in comparison to bone-related extramedullary relapse.

http://www.wikidata.org/entity/Q37552061

about

A multicenter phase 2 study of pomalidomide plus dexamethasone in patients with relapsed and refractory multiple myeloma: the Japanese MM-011 trial CXCR4-directed endoradiotherapy induces high response rates in extramedullary relapsed Multiple Myeloma Circulating Serum MicroRNA-130a as a Novel Putative Marker of Extramedullary Myeloma.A voluminous mass as an initial clinical symptom of multiple myeloma: A case report Involvement of the arachidonic acid cytochrome P450 epoxygenase pathway in the proliferation and invasion of human multiple myeloma cells.Management of high-risk Myeloma: an evidence-based review of treatment strategies.Current Review on High-Risk Multiple Myeloma.High-risk multiple myeloma: a multifaceted entity, multiple therapeutic challenges.The possible role of burden of therapy on the risk of myeloma extramedullary spread.Cytogenetics in multiple myeloma patients progressing into extramedullary disease.Apparent diffusion coefficient map of a case of extramedullary plasmacytoma.Development of extramedullary myeloma in the era of novel agents: no evidence of increased risk with lenalidomide-bortezomib combinations.Long non-coding RNA MALAT1 is an inducible stress response gene associated with extramedullary spread and poor prognosis of multiple myeloma.Multiple Extramedullary Plasmacytoma in a Setting of Complete Bone Marrow Remission: Food for Thought.Rare manifestations of extramedullary myeloma: testicular plasmacytomas.Impact of extramedullary disease in patients with newly diagnosed multiple myeloma undergoing autologous stem cell transplantation: A study from the Chronic Malignancies Working Party of the EBMT.The lymphoma-like polychemotherapy regimen "Dexa-BEAM" in advanced and extramedullary multiple myeloma.Durable treatment response of relapsing CNS plasmacytoma using intrathecal chemotherapy, radiotherapy, and Daratumumab.Prognostic Value of Baseline 18F-Fluorodeoxyglucose PET/CT in Patients with Multiple Myeloma: A Multicenter Cohort Study.

P2860

Q33431621-70C6389C-8329-4C54-A1F7-29DF14841C46 Q33703097-6308FF2E-ACCD-4811-B1A2-6F83E4653C6E Q35781800-0A0562BD-645D-4FB0-AA66-D41296CC975F Q36335530-05A16F87-CA1E-4021-8B68-588C4CD41809 Q36794225-0DDA9C4B-F780-488E-ACDC-AEA075C2A3C1 Q38874675-25099B42-6E33-4B88-A724-1380C6E08897 Q38895167-ADED8CD5-7B75-45D4-AEB8-5BCBCB8B7E6C Q38979403-D8A2ACA0-743A-4A0B-A796-F9724C0AEE44 Q39264310-E51EC26B-55D3-4363-8B1B-34001A08A5E0 Q40471885-41C59F06-9B9F-43D4-B137-E65FDBA1CEB8 Q41224463-A6383244-0EEA-47C0-94B9-97A6A3343DA6 Q41702673-266D1CCE-A314-4678-A816-7B4481C4B26D Q48300802-151EE617-F892-48F1-8526-8AC2992794C6 Q49734105-E279A7F2-50C0-43E1-9962-A1592BFA5760 Q50038926-1E13A6E9-4FD9-4E53-A6F4-797391BA33D4 Q50118881-BA4797F6-36B3-46F6-8B7F-F5066B2AEDC8 Q51753186-985E92BD-F205-4E53-87E8-AD5ECA1878C2 Q55332332-7A776C22-F930-4AFE-B651-690B123729FD Q55354701-995B2EA5-DC4E-4C97-9353-DB3BAED8C430

P2860

Soft-tissue extramedullary multiple myeloma prognosis is significantly worse in comparison to bone-related extramedullary relapse.

http://www.wikidata.org/entity/Q37552061

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 13 September 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Soft-tissue extramedullary mul ...... elated extramedullary relapse.

@en

Soft-tissue extramedullary mul ...... elated extramedullary relapse.

@nl

type

label

Soft-tissue extramedullary mul ...... elated extramedullary relapse.

@en

Soft-tissue extramedullary mul ...... elated extramedullary relapse.

@nl

prefLabel

Soft-tissue extramedullary mul ...... elated extramedullary relapse.

@en

Soft-tissue extramedullary mul ...... elated extramedullary relapse.

@nl

P1433

Q37552061-6719CF8F-3946-4C5C-ACF7-5A5140FE1D66

P1476

Q37552061-8DA49DB6-0406-4D39-9CF9-ED077486E248

P2093

Q37552061-07BFB129-CB5E-4814-B6E9-F32ADCC7DE44

Q37552061-12F7DCC3-9F67-438F-9670-F85E9B550137

Q37552061-16680EDD-F918-44E1-BC81-EF88BBCDF06B

Q37552061-1F31644D-C681-41C5-B41F-66239A053B76

Q37552061-22142825-3A34-4DAD-8C55-0E756B7A63EB

Q37552061-2ACAE1A9-D727-4060-A97F-91D9024F9C41

Q37552061-34D6EC3F-B151-4285-904B-13F72A9C832E

Q37552061-3F08A118-8A73-492B-9CB6-50AC5005925B

Q37552061-8272F57C-E5EE-481D-8C08-87B2AC03DAEB

Q37552061-9175406C-CA8A-4019-8019-D734D116A61C

P2860

Q37552061-1DECB3B4-FD34-490D-81C1-75AFA3A339EC

Q37552061-1F62B9DF-018F-4483-AF49-81E10B1D6FDE

Q37552061-224A5301-E44F-40A7-86F3-5F5F175D46C1

Q37552061-3C9629F5-7310-475E-8C9D-6414E0F19622

Q37552061-4B929370-6D0D-4596-BE1D-7A1B732439BB

Q37552061-51F407C9-CE05-44EB-8C04-9CB25076E970

Q37552061-5B148551-8B9D-44C3-8CCE-B1D8DFDE7E71

Q37552061-6AF2A462-CC24-463A-9A72-D8EFAA7CAE73

Q37552061-6B948DEE-E1FA-48C1-8D5F-CDD862E2BE56

Q37552061-77C64652-F022-4E91-83DC-7B9171C29454

P304

Q37552061-03CA872E-BFD5-4AD2-A51A-E2E5A10A7A54

P31

Q37552061-450E1D18-3F68-41CF-A638-88A6C74AF85F

P356

Q37552061-CBC589ED-EF71-451F-A53C-F3A1B9862925

P433

Q37552061-97244AAF-7C1A-44C1-BBAF-B7146C2AD2D3

P478

Q37552061-F77BFEFC-1B59-47A0-BB1D-2248B71D9311

P50

Q37552061-BA2041EE-2A66-4592-B029-BC9F4B19C1ED

P577

Q37552061-E14FD809-7B07-4A53-9BA4-E40204EA0CB6

P5875

Q37552061-B30BB63E-2065-435A-A09D-23F884D64FB6

P698

Q37552061-841AFAA4-4CFC-42C2-9533-18B794DA88AD

P932

Q37552061-B95023B7-5418-4A4E-A6FD-853294EB08A7

P356

HAEMATOL.2013.094409

P1433

P1476

Soft-tissue extramedullary mul ...... related extramedullary relapse

@en

P2093

Henrieta Greslikova

http://www.w3.org/2001/XMLSchema#string

Lenka Zahradova

http://www.w3.org/2001/XMLSchema#string

Ludek Pour

http://www.w3.org/2001/XMLSchema#string

Marta Krejci

http://www.w3.org/2001/XMLSchema#string

Petr Kuglik

http://www.w3.org/2001/XMLSchema#string

Petra Majkova

http://www.w3.org/2001/XMLSchema#string

Renata Kupska

http://www.w3.org/2001/XMLSchema#string

Sabina Sevcikova

http://www.w3.org/2001/XMLSchema#string

Viera Sandecka

http://www.w3.org/2001/XMLSchema#string

Zdenek Adam

http://www.w3.org/2001/XMLSchema#string

P2860

Solitary bone and extramedullary plasmacytoma

A phase 2 study of bortezomib in relapsed, refractory myeloma.

Lenalidomide plus dexamethasone for relapsed or refractory multiple myeloma.

Extramedullary disease portends poor prognosis in multiple myeloma and is over-represented in high-risk disease even in the era of novel agents.

Reiterative survival analyses of total therapy 2 for multiple myeloma elucidate follow-up time dependency of prognostic variables and treatment arms.

International Myeloma Working Group molecular classification of multiple myeloma: spotlight review.

Plasmacytoma relapses in the absence of systemic progression post-high-dose therapy for multiple myeloma.

Soft-tissue plasmacytomas in multiple myeloma: incidence, mechanisms of extramedullary spread, and treatment approach.

Multiple myeloma with extramedullary disease.

Gain of 1q21 is an unfavorable genetic prognostic factor for multiple myeloma patients treated with high-dose chemotherapy.

P304

360-364

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3324/HAEMATOL.2013.094409

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

99

http://www.w3.org/2001/XMLSchema#string

P50

P577

2013-09-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

256612624

http://www.w3.org/2001/XMLSchema#string

P698

24038024

http://www.w3.org/2001/XMLSchema#string

P932

3912968

http://www.w3.org/2001/XMLSchema#string